Last reviewed · How we verify
NWRD08 administered by electroporation
At a glance
| Generic name | NWRD08 administered by electroporation |
|---|---|
| Sponsor | Newish Biotech (Wuxi) Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL (PHASE2)
- NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |